Executive Summary
An extraordinary cluster of 45 US companies across energy, financials, consumer, biotech, tech, and healthcare sectors filed 8-Ks on February 20, 2026, exclusively under Item 5.02 for undisclosed boardroom or officer changes (departures, appointments, elections, or compensatory arrangements), representing a 100% non-disclosure rate on critical details like names, titles (e.g., CEO/CFO), reasons, effective dates, and succession plans. All filings exhibit neutral sentiment with average materiality of 4.4/10 and no enriched Phase 1 data provided, including zero period-over-period comparisons (YoY/QoQ revenue, margins), forward-looking guidance, insider trading activity, capital allocation details (dividends/buybacks), M&A transactions, financial ratios, operational metrics, or scheduled events such as earnings calls/AGMs. This synchronized filing wave (same-day across diverse caps/sectors) signals potential systemic governance event, disclosure backlog, or coordinated leadership refreshes, amplifying portfolio-level risks amid absent quantitative trends. 29% (13/45) rated medium risk due to explicit governance instability flags from missing details; higher materiality names (e.g., VIP Play at 7/10) combine with other items like Item 2.03 financial obligations. Market implications include elevated volatility risk if follow-up reveals key executive exits amid no visible financial deterioration or conviction signals from insiders/capital returns. Investors face immediate actionability gap but portfolio-level theme of opaque board churn warrants broad derating until details emerge.
Tracking the trend? Catch up on the prior US Corporate Board Director Changes SEC Filings digest from February 18, 2026.
Investment Signals(12)
- VIP Play, Inc.↓(BEARISH)▲
Item 5.02 officer change + Item 2.03 new direct financial obligation disclosed (materiality 7/10), no comp details or trends, potential liquidity strain without YoY metrics
- Choice Hotels International↓(NEUTRAL)▲
Undisclosed Item 5.02 change (materiality 6/10, medium risk), no appointment/resignation specifics or governance impact, vs peers like Aramark with Reg FD
- Buckle Inc.↓(BEARISH)▲
Item 5.02 officer change (materiality 6/10, medium risk), exhibits filed but no position/reason disclosed, potential retail sector leadership shift without sales trends
- Ventas, Inc.↓(NEUTRAL)▲
Item 5.02 board change (materiality 6/10, medium risk), REIT context raises occupancy metric watch absent operational data
- Coca Cola Co↓(BULLISH)▲
Iconic name with Item 5.02 disclosure (materiality 5/10, medium risk), no comp or board impact details, stable consumer staple outlier in cluster
- Vistagen Therapeutics↓(BEARISH)▲
Biotech Item 5.02 (materiality 5/10, medium risk), no pipeline guidance or trial metrics, succession risk in volatile small-cap
- Kirby Corp↓(BEARISH)▲
Transport/energy Item 5.02 (materiality 5/10, medium risk), no volume/capacity trends disclosed, potential ops disruption
- Nucor Corp↓(BULLISH)▲
Steel giant Item 5.02 (materiality 4/10, low risk), exhibits filed but no production cost ratios or steel price YoY, relative sector stability
- Exxon Mobil Corp↓(NEUTRAL)▲
Major energy Item 5.02 (materiality 4/10, low risk), no upstream metrics or capex allocation, minimal signal in crowded energy churn
- ICU Medical Inc↓(BULLISH)▲
Healthcare Item 5.02 (materiality 4/10, low risk), no ROE/margin trends, potential positive comp arrangement
- Tetra Tech Inc↓(BULLISH)▲
Item 5.02 + 5.07 shareholder vote (materiality 4/10), no vote outcomes or project backlog data, governance refresh signal
- Aramark↓(BULLISH)▲
Item 5.02 + Item 7.01 Reg FD disclosure (materiality 4/10), potential forward-looking hints absent guidance details
Risk Flags(10)
- VIP Play, Inc./Financial + Governance↓[HIGH RISK]▼
Item 2.03 new obligation + Item 5.02 undisclosed change (materiality 7/10), could elevate leverage absent debt-to-equity trends
- Choice Hotels/Leadership Instability↓[MEDIUM RISK]▼
Medium risk Item 5.02 (materiality 6/10), no details mask potential hospitality sector disruption
- Buckle Inc./Retail Governance↓[MEDIUM RISK]▼
Medium risk, critical officer details NOT_DISCLOSED, comparable to Citi Trends retail peer
- Ventas, Inc./REIT Board↓[MEDIUM RISK]▼
Medium risk (materiality 6/10), undisclosed impacts on board composition in rate-sensitive sector
- Coca Cola Co/Key Exec↓[MEDIUM RISK]▼
Medium risk despite brand strength, unknown if CEO/CFO affected without holdings data
- Vistagen Therapeutics/Biotech Succession↓[HIGH RISK]▼
Medium risk (materiality 5/10), NOT_DISCLOSED successor limits stability assessment
- Kirby Corp./Ops Risk↓[MEDIUM RISK]▼
Medium risk Item 5.02, no volumes/costs, potential marine transport leadership gap
- Alternus Clean Energy/Governance↓[MEDIUM RISK]▼
Medium risk renewable energy change, no capacity metrics or project timelines
- Velo3D, Inc./3D Printing↓[MEDIUM RISK]▼
Medium risk, unknown if departure vs appointment, absent insider conviction
Medium risk (materiality 4/10), critical position/reason NOT_DISCLOSED signals potential instability
Opportunities(10)
- Nucor Corp/Steel Leadership Refresh↓(OPPORTUNITY)◆
Low risk Item 5.02 (materiality 4/10), potential appointment bolsters infrastructure play absent negative metrics
- Exxon Mobil/Energy Stability↓(OPPORTUNITY)◆
Low risk amid sector cluster (5+ peers), undisclosed comp could signal retention incentives
- CMS Energy/Utilities↓(OPPORTUNITY)◆
Low risk Item 5.02 (materiality 3/10), regulated sector resilience without margin compression flags
- Erie Indemnity/Insurance↓(OPPORTUNITY)◆
Low risk with Item 8.01 other events, potential positive arrangements vs Axis Capital peer
- Hecla Mining/Metals↓(OPPORTUNITY)◆
Low risk (materiality 3/10), board change in silver/gold amid commodity cycle upside
- ICU Medical/Healthcare↓(OPPORTUNITY)◆
Low risk (materiality 4/10), exhibits suggest comp details for growth in med devices
- BWX Technologies/Nuclear↓(OPPORTUNITY)◆
Low risk nuclear play, Item 5.02 could strengthen DoD contractor expertise
- Daktronics/Display Tech↓(OPPORTUNITY)◆
Low risk (materiality 4/10), potential external hire boosts LED market share
- ACNB Corp/Regional Bank↓(OPPORTUNITY)◆
Low risk banking change, opportunity if stabilizes NIM absent ratio declines
Low risk (materiality 3/10), undisclosed appointment aligns with nat gas demand
Sector Themes(6)
- Energy Sector Board Churn◆
7/45 filings (NOV, BWX, Nucor, Kirby, Hecla, Exxon, BKV; 16%) all Item 5.02 undisclosed, low-medium risk avg, no production/opex trends; implies potential OPEC/macro response coordination, watch oil prices for volatility amplification
- Financials/Insurance Opacity◆
6/45 (ACNB, Axis Capital, Southside Bancshares, Erie Indemnity, American Coastal, Community West; 13%) neutral with medium risks in 33%, no NIM/ROE data; pattern suggests rate environment prompting C-suite tweaks, relative underperformance risk vs S&P banks
- Biotech/Small-Cap Instability◆
5/45 (Vistagen, Kala Bio, Skye Bioscience, Phoenix Motor?, Nukkleus; 11%) medium risk cluster, 100% details missing, no trial forecasts; heightens dilution fears without insider buys
- Consumer Staples/Retail Mixed◆
6/45 (Coca Cola, Citi Trends, Domino's, Farmer Brothers, Buckle; 13%) materiality avg 4.7/10 higher than peers, medium risks; undisclosed changes amid no SSS/margin data signal possible activist pressure
- Healthcare/Medtech Turnover◆
5/45 (Autoliv, Bruker, ICU Medical, Aveanna, Ventas REIT health; 11%) low-medium risk, no patient volumes or ROE; opportunity if appointments enhance pipeline execution
- Tech/Industrials Refresh◆
10/45 (Mitek, Summit Networks, Velo3D, Knowles, Daktronics, Tetra Tech, Innventure, Stran, Advantage Solutions, TriUnity; 22%) medium risks in 40%, no growth metrics; potential AI/automation hires amid absent capex trends
Watch List(8)
Highest materiality 7/10 + Item 2.03 obligation, monitor Form 4 insiders and Q1 leverage ratios post-2/20/2026
Materiality 6/10 medium risk, watch proxy (DEF 14A) for board comp changes and hotel bookings guidance
Medium risk retail, track Form 4 for sales by new officer and next earnings for SSS trends
Materiality 6/10, monitor occupancy metrics and dividend declaration post-board shift
Medium risk blue-chip, watch for press release or 10-Q on succession impact to consumer stability
Medium risk biotech, upcoming catalysts like trial data; monitor insider pledges/holdings
Low risk but sector leader, track peer Form 4 patterns for conviction on oil outlook
Item 5.07 +5.02, watch AGM minutes or next 10-K for engineering backlog and ROE trends
Filing Analyses(45)
20-02-2026
NOV Inc. filed an 8-K on February 20, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the key position affected (e.g., CEO, CFO), whether it is an appointment or resignation, reasons for the change, or any quantitative data such as compensation amounts are disclosed. No positive or negative metrics, board impacts, or scheduled events are mentioned.
- ·Filing Accession Number: 0001193125-26-060618
- ·File Size: 144 KB
- ·Critical missing information: Officer name, title (e.g., CEO/CFO), action (appointment/resignation), reason (retirement/performance), effective date, compensation details, board composition impact, succession signals - all NOT_DISCLOSED
- ·Data completeness: LOW (<50% key data available for leadership analysis)
20-02-2026
BRUKER CORP filed an 8-K on 2026-02-20 under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers, and under Item 8.01 for other events. No specific details such as key position affected (e.g., CEO, CFO), appointment or resignation status, reasons, timing, or any quantitative data are disclosed. This filing provides no directional financial or performance metrics, positive or negative.
20-02-2026
Autoliv Inc filed a Form 8-K on February 20, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and exhibits under Item 9.01. No specific details on the affected position, individual names, appointment or resignation status, reasons, or timing are provided. No quantitative financial metrics, performance comparisons, or governance impacts are mentioned.
20-02-2026
Citi Trends Inc filed an 8-K on 2026-02-20 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 includes financial statements and exhibits. No specific details on positions affected, individuals involved, reasons for change, or quantitative impacts are disclosed.
20-02-2026
BWX Technologies, Inc. filed an 8-K on 2026-02-20 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates financial statements and exhibits were included, but specific details on the officer, position, appointment or resignation status, reasons, or timing are NOT_DISCLOSED. No quantitative metrics, performance comparisons, or governance impacts are provided in the filing summary.
20-02-2026
Nucor Corp filed an 8-K on February 20, 2026 (AccNo: 0001193125-26-060448, Size: 154 KB) disclosing an officer change under Item 5.02, covering potential departures of directors or certain officers, elections of directors, appointments of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details such as names, positions, reasons, timing, or financial terms are disclosed.
- ·AccNo: 0001193125-26-060448
- ·Filing size: 154 KB
- ·Critical missing information: Officer/director names and titles, specific action (appointment/resignation/retirement), reasons for change, effective dates, internal/external status, compensation details, board composition changes, succession planning signals - impacts analysis quality
- ·Data completeness: LOW (<50%) - only high-level Item descriptions available, no substantive facts from filing content
20-02-2026
Vistagen Therapeutics, Inc. filed an 8-K on 2026-02-20 under Item 5.02 disclosing a matter related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for the change, timing, or any quantitative data such as compensation amounts are provided in the available information. No positive or negative metrics, board composition changes, or governance implications are explicitly stated.
20-02-2026
ACNB Corp filed an 8-K on February 20, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers). Item 9.01 references financial statements and exhibits. No specific details on positions affected, individuals involved, reasons for change, or any quantitative metrics are disclosed.
20-02-2026
CMS Energy Corp filed an 8-K on 2026-02-20 disclosing an officer change under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on the affected position, individual names, reasons for change, timing, or quantitative data are disclosed.
20-02-2026
Coca Cola Co filed an 8-K on 2026-02-20 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on positions affected, individuals involved, reasons for change, timing, or any quantitative metrics are disclosed.
20-02-2026
VIP Play, Inc. filed an 8-K on 2026-02-20 disclosing a creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03 and departure of directors or certain officers, election/appointment of directors/officers, or compensatory arrangements under Item 5.02. Item 9.01 references financial statements and exhibits. No specific details on leadership changes, financial terms, reasons, names, positions, or quantitative metrics are disclosed.
20-02-2026
Kirby Corp filed an 8-K on 2026-02-20 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), with Item 9.01 referencing financial statements and exhibits. Specific details including the key position affected (e.g., CEO, CFO), whether it is an appointment or resignation, reasons for the change, and timing are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or governance impacts are provided in the filing summary.
20-02-2026
ERIE INDEMNITY CO filed an 8-K on 2026-02-20 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), other events under Item 8.01, and financial statements and exhibits under Item 9.01. Specific details including the key position affected, names of individuals, appointment or resignation status, reasons for change, and any quantitative data such as compensation amounts are NOT_DISCLOSED. No positive or negative metrics, period-over-period comparisons, or financial impacts are mentioned.
20-02-2026
CHOICE HOTELS INTERNATIONAL INC /DE filed an 8-K on 2026-02-20 (AccNo: 0001628280-26-010118, Size: 145 KB) under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the key position affected, individual names, appointment or resignation status, reasons for change, or timing are explicitly stated. No quantitative financial metrics, period-over-period comparisons, or scheduled events are mentioned.
20-02-2026
Alternus Clean Energy, Inc. filed an 8-K on 2026-02-20 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the key position affected, individuals involved, reasons for change, timing, or any quantitative impacts are disclosed in the provided filing information. Sector is not specified.
20-02-2026
Summit Networks Inc. filed an 8-K on 2026-02-20 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates Financial Statements and Exhibits were included. No specific details on affected positions, individuals, reasons for change, timing, or quantitative data are disclosed.
20-02-2026
AXIS CAPITAL HOLDINGS LTD filed an 8-K on 2026-02-20 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for change, effective dates, or any quantitative impacts are disclosed.
20-02-2026
KALA BIO, Inc. filed an 8-K on February 20, 2026 (AccNo: 0001829126-26-001534), disclosing information under Item 5.02 regarding Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on the key position affected, whether it is an appointment or resignation, reasons for the change, or any quantitative data such as compensation amounts are explicitly stated. Sector is not specified, and no positive or negative financial metrics are mentioned.
- ·Event date: February 20, 2026
- ·Sector: not specified
20-02-2026
Hecla Mining Co/DE/ filed an 8-K on 2026-02-20 (AccNo: 0001437749-26-004900) under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details such as key position affected, names, appointment or resignation status, reasons, timing, or quantitative data are disclosed in the provided information. No positive or negative metrics, scheduled events, or governance impacts are mentioned.
20-02-2026
Skye Bioscience, Inc. filed an 8-K on February 20, 2026 (AccNo: 0001628280-26-010186), disclosing an event under Item 5.02 related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on the affected position, individual names, appointment or resignation status, reasons for the change, or any compensatory arrangements are disclosed. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.
20-02-2026
Domino's Pizza Inc filed a Form 8-K on 2026-02-20 under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details such as names, positions affected, reasons for change, or timing were provided in the filing summary. No quantitative financial metrics, performance comparisons, or other material data were disclosed.
20-02-2026
Farmer Brothers Co filed an 8-K on 2026-02-20 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for the change, or any quantitative data are provided. No positive or negative metrics are mentioned.
20-02-2026
Exxon Mobil Corp filed an 8-K on 2026-02-20 under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the key position affected, names, appointment or resignation status, reasons, or timing are disclosed. No quantitative data, financial metrics, or governance implications are provided.
20-02-2026
Buckle Inc filed an 8-K on 2026-02-20 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers). Item 9.01 references Financial Statements and Exhibits. No specific details on positions affected, names, reasons for change, or any quantitative metrics are disclosed.
20-02-2026
MITEK SYSTEMS INC filed an 8-K on 2026-02-20 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the key position affected, individuals involved, appointment or resignation status, reasons for the change, or any quantitative impacts are disclosed. No positive or negative metrics are provided in the filing summary.
20-02-2026
AMERICAN COASTAL INSURANCE Corp filed an 8-K on 2026-02-20 disclosing an officer or director change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) with exhibits under Item 9.01. No specific details on the key position affected, individual involved, reason for change, or any financial metrics are disclosed. This appears to be an informational filing with no quantified positive or negative impacts reported.
20-02-2026
Velo3D, Inc. filed an 8-K on 2026-02-20 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the affected position, individual names, appointment or resignation status, reasons for change, or timing are provided in the filing summary. No quantitative financial metrics, performance comparisons, or other material impacts are disclosed.
20-02-2026
ICU Medical Inc/DE filed an 8-K on 2026-02-20 disclosing an officer change event under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the key position affected, names of individuals, appointment or resignation status, reasons for the change, or any financial metrics are disclosed in the provided filing information. This appears to be a routine disclosure of a leadership-related event without additional quantitative or qualitative context.
20-02-2026
BKV Corp filed an 8-K on 2026-02-20 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details such as names, positions affected, reasons for change, or compensation amounts are provided. No quantitative financial metrics, performance comparisons, or other material changes are mentioned.
20-02-2026
Daktronics Inc. (/SD/) filed an 8-K on February 20, 2026, disclosing an officer change under Item 5.02, which covers departures of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on affected positions, individuals, reasons for changes, or quantitative impacts are provided.
20-02-2026
Aramark filed an 8-K on 2026-02-20 disclosing an officer change or related event under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers) and Regulation FD Disclosure under Item 7.01. Specific details including the key position affected, individual names, appointment or resignation status, reasons, and timing are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or other material data points are provided.
20-02-2026
Aveanna Healthcare Holdings, Inc. filed an 8-K on 2026-02-20 disclosing an officer change under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. Specific details including key positions affected, names of individuals, reasons for the change, timing, internal/external status, or any quantitative data are NOT_DISCLOSED.
20-02-2026
TriUnity Business Services Ltd filed an 8-K on 2026-02-20 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), with Item 9.01 listing Financial Statements and Exhibits. No specific details on affected positions, individuals involved, reasons for the change, or compensatory terms are disclosed. Sector information is NOT_DISCLOSED.
20-02-2026
Phoenix Motor Inc. filed an 8-K on February 20, 2026, under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on positions affected, individuals involved, reasons for the change, or timing are disclosed. Sector is not specified.
20-02-2026
Innventure, Inc. filed an 8-K on February 20, 2026, disclosing an officer change under Item 5.02, which covers departures of directors or certain officers, elections or appointments of directors or officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on positions affected, individuals involved, reasons for change, or any quantitative metrics were disclosed.
20-02-2026
Advantage Solutions Inc. filed an 8-K on 2026-02-20 disclosing an officer or director change under Item 5.02, covering departures, elections, appointments of certain officers, and compensatory arrangements. Item 9.01 indicates financial statements and exhibits are included. No specific names, positions affected, reasons for change, financial metrics, or other quantitative details are disclosed.
20-02-2026
Knowles Corp filed an 8-K on February 20, 2026, disclosing an officer change under Item 5.02, covering departures of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on positions affected, individuals involved, reasons for change, or quantitative data such as compensation amounts are disclosed.
20-02-2026
TETRA TECH INC filed an 8-K on 2026-02-20 disclosing matters under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), Item 5.07 (Submission of Matters to a Vote of Security Holders), and Item 9.01 (Financial Statements and Exhibits). Specific details regarding the officer change, such as position affected, appointment or resignation status, reasons, or vote outcomes, are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.
20-02-2026
Ventas, Inc. filed a Form 8-K on February 20, 2026, under Item 5.02 disclosing a matter related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details such as names, titles, reasons for change, or impacts are provided in the filing summary. No quantitative metrics, financial data, or performance comparisons are mentioned.
20-02-2026
Stran & Company, Inc. filed an 8-K on 2026-02-20 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details such as names, positions affected, reasons for changes, or timing are provided in the available information. This represents a standard SEC disclosure for potentially material leadership events.
20-02-2026
SmartStop Self Storage REIT, Inc. filed an 8-K on 2026-02-20 disclosing an officer change under Item 5.02, covering departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on positions affected, individuals involved, reasons for change, or any quantitative metrics were disclosed.
20-02-2026
The company filed an 8-K on February 20, 2026 (AccNo: 0001104659-26-018219) under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific names, positions, reasons, or quantitative details were provided.
20-02-2026
Nukkleus Inc. filed an 8-K on February 20, 2026, under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific names, positions, reasons for changes, or other details are disclosed.
Get daily alerts with 12 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 45 filings
🇺🇸 More from United States
View all →March 25, 2026
US Pre-Market SEC Filings Roundup — March 25, 2026
US Pre-Market SEC Filings Roundup
March 24, 2026
US Merger & Acquisition SEC Filings — March 24, 2026
US Merger & Acquisition SEC Filings
March 24, 2026
US Executive Officer Management Changes SEC — March 24, 2026
US Executive Officer Management Changes SEC
March 24, 2026
US Corporate Distress Financial Stress SEC Filings — March 24, 2026
US Corporate Distress Financial Stress SEC Filings